APPLICATION
BLA103786
TYPE
BLA
ORIGINAL APPROVAL
1998-05-06
LATEST ACTION
1998-05-06
DOSAGE FORM
VIAL
MARKETING STATUS
Prescription
Products
RETAVASEPrescription
RETEPLASE 18.8MG/VIAL · VIAL
Approval history
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.